This past mothers day weekend I attended the Shirley Mae Run & Gilda's Club Walk held in Atlantic City, New Jersey. It was a beautiful Saturday to take a stroll on the boardwalk. My dad flew in from Arizona for the event and my mom drove from Philadelphia. I'm very lucky that my parents are so supportive.

The Shirley Mae Breast Cancer Assistance Fund was started by Roy Goldberg to honor his mother, Shirley Mae, who survived breast cancer. The fund assists breast cancer patients in the south-eastern area of New Jersey with the cost of medicine, wigs, prostheses, and anything else needed to relieve financial stress so they can focus on healing and becoming survivors too.

Former televangelist Tammy Faye Messner -- formerly Tammy Faye Bakker -- posted Tuesday on her website (service is currently unavailable) a message about her health.

Messner, 65, reports that doctors have stopped treating her cancer -- she was diagnosed with colon cancer in 1996 and announced in 2004 the disease had spread to her lungs.

"I am down weight-wise to 65 pounds, and look like a scarecrow," the Charlotte resident shared on her site. "I need God's miracle to swallow. I look at young people and wish with all my heart for just one day of 'feeling great.'"

My husband came up with this idea he thought I should pursue. Why not contact the makers of bras, he suggested, and encourage them to sew some kind of pink ribbon or inspirational message inside these undergarments so women are reminded of the importance of breast health every time they get dressed? Because I don't have enough time right now, I told him, thinking maybe one day when my two little boys are all grown up and I have time for myself I will focus my energy on some worthwhile cause.

A few days after my husband shared his brainstorm with me, I read about a woman who has spearheaded a project very similar to the one he was dreaming of. Great minds think alike.

Think about this:

Advocacy runs far and wide. Thank goodness for that.

Think about this:

A new breast cancer non-profit organization has been launched especially for South Africans affected by the disease.

Founded by Samantha Galliet, the 31-year-old breast cancer survivor who made headlines with her "David and Goliath" battle to get life-saving Herceptin treatment, created PinkLink to give patients affected by breast cancer a voice.

PinkLink, focusing on the need for self-examination and awareness to encourage prevention and early detection of this silent epidemic, is intended to be a one-stop-shop with valuable South African based information on doctors, treatments, financial considerations, and health issues.

Today I offer you not so much a Thought for the Day but a Question for the Day. Before I ask my pressing question, though, I want you to consider this story.

Diagnosed with a rare malignant melanoma on her retina in 2001, Ann Guthrie, a South Carolina wife and mother of two grown sons, endured radiation and chemotherapy. The treatments shrunk Guthrie's tumor, but another mass appeared two years later, forcing the removal of her right eye.

At about the same time Guthrie lost her eye, cancer was discovered in her lungs. It was inoperable. Then cancer landed in her brain. And now, without any approved treatment avenues, Guthrie is out of options.

Like many people with terminal illnesses, this woman is willing to try just about anything -- a clinical trial, experimental drugs, risky treatments -- to extend her life. If she's going to die anyway, why not? She just might live longer. And if she doesn't, she could at least help advance science by offering herself up as a sort of guinea pig.

While the Food and Drug Administration (FDA) has proposed changes that would make it easier for patients to access options like these, it's just not that simple right now.

There are ethical issues -- like weighing the needs of people who think anything is better than death against the need of society to prove drugs and treatments work safely. The only way to ensure a sort of balance is through clinical trials -- and letting anyone participate in clinical trials, for example, would make the results harder to interpret.

And there are medical and legal risks. What if terminally ill patients end up in worse shape after a treatment with an experimental drug, for example? What if the FDA or a physician is considered responsible for adverse drug reactions?

Denying terminal patients their last bits of hope is difficult. "It's a hard discussion to have with a patient and his family," says one doctor. "There's a lot of tears. We all would love to be able to get them access to some form of therapy."

And now for my question:

What do you think about terminally ill cancer patients and their access to anything that might extend -- or save -- their lives?

This year alone, 215,000 women will be diagnosed with breast cancer. And sadly, not all of them will be treated equally.

Researchers reported last Tuesday that breast cancer patients who are either obese or poor are more likely to receive lower doses of chemotherapy. This might be why some women relapse and others do not, according to the researchers whose findings appear in the Journal of Clinical Oncology.

This treatment discrepancy seems to stem from doctors who mean well and want to save certain women from severe side effects of chemotherapy. Doctors may be under-dosing obese patients, for example, because a larger dose based on weight could lead to worse side effects. There is no evidence this is true, however.

As for socioeconomic status, researchers report doctors are assuming less-educated patients won't stick with a tough course of treatment -- and so they prescribe less, in hopes patients will complete the regimen.

Researchers found that severely obese women were four times more likely to get less chemotherapy than they need. Women with less than a high school education were three times more likely to receive low doses of chemotherapy. And women living in the South were almost six times more likely to come up short on the drugs they need to save their lives.

"We have new therapies and cures out there for many forms of cancer and sadly, sometimes we're not curing people because they are not getting the full doses that should be standard," says Dr. Gary Lyman who led the study at the University of Rochester Medical Center in New York.

Tampa's H. Lee Moffitt Cancer Center & Research Institute, the only comprehensive cancer center in Florida, has just partnered with Merck & Co., one of the world's largest drug companies, to develop personalized cancer treatments using a patient's genetic profile.

The two powerhouse entities will form a for-profit company called M2Gen on donated land near the University of South Florida. And in the span of just a few years, researchers plan to compile a database of tumor tissue and other medical information to determine why some patients respond to treatment while others do not. The database could house information on more than 30,000 patients within five years and will enable researchers to identify biological markers that could help doctors choose the most effective treatment based on the genetic make-up of each patient's tumor.

Blind treatment -- where everyone receives the same thing -- will be a thing of the past as tailor-made therapies replace the one-size-fits-all approach.

Florida Governor Jeb Bush says of the partnership that will create more than 170 high-paying jobs, "Man, I don't know if you can think of a better Christmas present than that."

The University of Miami's first basketball All-American and member of the school's Athletic Hall of Fame died Friday of esophageal and colon cancer. Dick Hickox, a 5-6 guard who led the 1959-60 Hurricanes to a 23-3 record and a No. 8 ranking -- still the school's highest -- was 68 years old.

Hickox never meant to play basketball at UM. He went to Coral Gables with a friend who was homesick and who threatened to leave unless coach Bruce Hale brought in Hickox and a another friend. Hale agreed -- and had no idea what he was getting. Hickox averaged 22.1 points that season and went on to make history. He was named second All-American, alongside Providence guard Lenny Wilkens. Hickox drew crowds of 5,000 and celebrities -- like actors Burt Reynolds, George Hamilton, and then-Cassius Clay -- often cheered him on from under the basket.

Hickox spent his adult years working in the Dade County Public School system and was the business manager of the South Miami High athletic department. In March, he attended the Atlantic Coast Conference tournament in Greensboro, N.C., and received a Legends Award. It was the best basketball weekend of his life, one friend said.

Hickox is survived by his wife, his son, and his daughter.

The bikini turns 60 this month and makes news not just for its birthday but also for its new feature -- a built-in alarm to warn wearers to get out of the sun. Not all bikinis will talk -- but those made by Canadian company Solestrom will. Solestrom has created a new bikini that goes on sale next month with a UV meter built into its belt and an alarm that sounds when it's time to seek shade. The meter on the $190 bikini displays a level of UV intensity on a scale from 0 to 20. Three to five is moderate strength, eight to 10 is very high, and anything above 11 is extreme. A person's sensitivity to UV depends mainly on skin type so this scale operates in general terms.

Despite increasing awareness of the sun's dangers, sales remain strong for the bikini. So Solestrom developed this suit to ease some of the worries about the sun's damaging rays. They have already been met with high demand from Australia and South Africa -- where skin cancer rates are highest. The United States -- now in the loop too -- has about 1 million new skin cancer cases each year.

While the effectiveness of a seaweed extract acting as a potent inhibitor of human papilloma viruses, HPV, that can lead in some cases to cervical cancer, has not been tested in any human clinical trials -- in the lab it has impressed the National Cancer Institute researchers who have been studying it.

According to researchers, carrageenan extracted from marine red algae (seaweed) showed a thousand-fold greater potency compared with other inhibitors they have tested in halting HPV.

Dr. John Schiller, senior investigator at the National Cancer Institute, who was involved in the development of the HPV vaccine, made the carrageenan discovery.

Schiller cautions that the results do not prove that carrageenan will work as a practical HPV topical microbicide. However, the positive results in the lab, together with the fact that carrageenan-based over-the-counter products are already available -- make carrageenan look even more promising to researchers in blocking the sexual transmission of HPV.

The new cervical cancer vaccine is effective for about 70 percent of the HPV viruses that can cause cervical cancer. It is also an expensive vaccine that might prove cost prohibitive for low-income women in economically distressed countries. The researchers think, if carrageenan proves as effective in human clinical trails as it has in the lab, the inexpensive carrageenan could be a significant benefit in the prevention of HPV.

One researcher, Dr. Connie Trimble, an HPV researcher at Johns Hopkins University, feels so positive about the recent advancements and discoveries in relation to cervical cancer that she said, "With all the potential tools now, we could really start to think about the end of cervical cancer. Between the vaccines and some of the prophylactics -- wouldn't that be a medical success story!"

When Amy Turner Tunick, an actress and writer who wrote The Feel Good Column for the South Florida Sun-Times, was first diagnosed with cancer she wrote:

"It doesn't seem real. There were no signs or symptoms. Maybe it's a genetic thing. But will I ever really know? I've been a very healthy active 44 year-old woman. I don't drink or smoke.  But, sometimes, unfortunate things do happen to good people. And I don't doubt I'm a good person. Actually, I believe I'm an exceptional person. I'm positive, optimistic, inspiring and enthusiastic. I try to be caring, loving and honest. So, sadly, I'm not blaming anyone, including God, that I've just been diagnosed with pancreatic cancer." 

Tunick did not exaggerate when she described herself as a positive, optimistic, inspiring and enthusiastic person. Her columns reflected that, and she had a way of inspiring the reader to feel optimistic about life. She had a way of reminding you of the simple joys of life and the importance of the people in your life. In one of her last columns, she wrote, ''Cry, scream, feel sorry for yourself -- but not for long. Basically, this is all about hope. Never lose it. Never give in or give up.''

Tunick had this to say about death, "I believe that Death teaches us that the time is now. The time is now to pick up a telephone and call the person that you love. Death teaches us the joy of the moment. It teaches us we don't have forever. If teaches us that nothing is permanent. It teaches us to let go, there's nothing you can hang on to. And it tells us to give up on expectations and let tomorrow tell its own story, because nobody knows if they'll get home tonight."

Tunick won't be getting home tonight. She lost her battle to cancer and the world lost more of its light. Tunick was 47.